Table V.
Summary of SAEs Relateda to Hypertension Medications
| Aggressive Group | Standard Group | P Value b | |
|---|---|---|---|
| Participants with ≥1 SAEs, % | 1.45 (0.04–2.86)c | 0.74 (−0.28–1.76) | .69 |
| Number of SAEs | 4 | 2 | .41 |
| Outcome of SAEs | |||
| Death | 0 | 0 | |
| Life‐threatening event | 0 | 0 | |
| Prolongation of hospital stay | 0 | 0 | |
| Event resulting in permanent disability | 0 | 0 | |
| Hospitalization | 4 | 2 | |
| Symptoms of SAEs | |||
| Syncope (pre‐syncope) | 2 | 1 | |
| Hypotension | 0 | 2 | |
| Acute renal failure | 1 | 0 | |
| Hyperkalemia | 2 | 0 | |
Abbreviation: SAEs, serious adverse events. aPossibly, probably, or definitely related. bChi‐square test was used to calculate the P value. cNumbers in parentheses are 95% confidence interval for percentages.